Kaplan Myron 4

What Happened

• Myron Kaplan, a director of CorMedix Inc. (CRMD), received an award of 30,453 restricted stock units (RSUs) on January 26, 2026. The filing reports the RSUs were granted at $0.00 (no purchase price), so the grant value at issuance is listed as $0.

Key Details

• Transaction date: 2026-01-26 (reported on Form 4 filed 2026-01-27)
• Transaction type/code: Award/Grant (A)
• Shares/units granted: 30,453 RSUs; grant price shown as $0.00
• Vesting: RSUs vest in full on January 26, 2027, subject to continued service (footnote F1)
• Beneficial ownership: Reporting person disclaims beneficial ownership of these securities (footnote F2)
• Shares owned after transaction: Not specified in the filing
• Filing timeliness: Filed the next day (appears timely); Exhibit 24.1 (Power of Attorney) included in the filing

Context

• RSUs represent a right to receive common stock upon vesting and do not involve an immediate cash purchase or sale. Because these units vest in a year (subject to continued service), they do not reflect an immediate change in market holdings and are a common form of compensation for directors. The F2 disclaimer is standard language and does not change the grant terms.